MARKET

KRRO

KRRO

Korro Bio, Inc.
NASDAQ
9.00
+0.19
+2.16%
Opening 15:00 10/14 EDT
OPEN
8.62
PREV CLOSE
8.81
HIGH
9.13
LOW
8.34
VOLUME
124.94K
TURNOVER
--
52 WEEK HIGH
55.89
52 WEEK LOW
5.20
MARKET CAP
132.53M
P/E (TTM)
-0.8997
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KRRO last week (1005-1009)?
Weekly Report · 2d ago
Korro Bio Doses First Cohort In Phase 1/2 Study Of KRRO-121 For Hyperammonemia
NASDAQ · 10/07 05:34
Oppenheimer Reaffirms Their Buy Rating on Korro Bio (KRRO)
TipRanks · 10/06 11:55
Piper Sandler Reaffirms Their Buy Rating on Korro Bio (KRRO)
TipRanks · 10/06 11:15
Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO), Korro Bio (KRRO) and HeartBeam (BEAT)
TipRanks · 10/06 10:40
Buy Rating Reiterated on KRRO as Early Clinical Execution, ANCHOR Trial Design and Cash Runway Support Unchanged $21 Price Target
TipRanks · 10/06 10:35
Korro Bio Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones · 10/06 10:26
HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $15 Price Target
Benzinga · 10/06 10:16
More
About KRRO
Korro Bio, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Using its oligonucleotide-based approach, the Company brings its medicines to patients by leveraging its proprietary platform. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD) that has the potential to be disease-modifying and provide a differentiated therapeutic option.

Webull offers Korro Bio Inc stock information, including NASDAQ: KRRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRRO stock methods without spending real money on the virtual paper trading platform.